Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
36 studies found for:    " September 15, 2010":" October 15, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Unknown  Umbilical Cord Mesenchymal Stem Cells for Immune Reconstitution in HIV-infected Patients
Conditions: Human Immunodeficiency Virus;   Disorder of Immune Reconstitution
Interventions: Drug: high dose of MSC;   Drug: low dose of MSC treatment
22 Completed ZIAGEN® Post-marketing Surveillance
Condition: Infection, Human Immunodeficiency Virus I
Intervention: Drug: ZIAGEN®
23 Terminated Dose-finding Study of GSK2248761 in Antiretroviral Therapy-Naive Subjects (SIGNET)
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: GSK2248761 100 mg once daily;   Drug: GSK2248761 200 mg once daily;   Drug: Efavirenz 600 mg once daily
24 Completed Correlating Protection Against Malaria With Serum Profiles Against Plasmodium Falciparum Antigen Repertoires
Conditions: Malaria;   Schistosomiasis;   Hiv Infection
Intervention:
25 Completed A Phase 1, Open Label, Placebo-Controlled Study to Evaluate the Effect of GSK1349572 on Iohexol and Para-Aminohippurate Clearance in Healthy Subjects
Condition: Infections, Human Immunodeficiency Virus and Tuberculosis
Interventions: Drug: GSK1349572;   Drug: Placebo;   Drug: Iohexol Injection;   Drug: Para-aminohippurate infusion
26 Completed
Has Results
Immunogenicity of Fluzone HD,A High Dose Influenza Vaccine, In Children With Cancer or HIV
Conditions: HIV;   Cancer
Interventions: Biological: Fluzone High Dose Vaccine;   Biological: Fluzone Standard Dose Vaccine
27 Completed A Study to Assess the Relative Bioavailability of Tablet Formulations of GSK2248761 in Healthy Adult Subjects. SGN114435
Conditions: Infections, Human Immunodeficiency Virus and Herpesviridae;   Infection, Human Immunodeficiency Virus
Interventions: Drug: GSK2248761 WBM Capsule;   Drug: GSK2248761 WBM Tablet Formulation 1;   Drug: GSK2248761 WBM Tablet Formulation 2;   Drug: GSK2248761 WBM Tablet Formulation 3;   Drug: GSK2248761 WBM Tablet
28 Completed GSK1349572 Hepatic Impairment Study
Conditions: Healthy Subjects;   Hepatic Impairment;   Infection, Human Immunodeficiency Virus
Intervention: Drug: GSK1349572
29 Completed Young Women's CoOp Study
Conditions: HIV;   Sexual Risk;   Sexually Transmitted Diseases;   Substance Abuse;   Violence;   Victimization
Interventions: Behavioral: Young Women's CoOp;   Behavioral: Staying Healthy and Eating Well
30 Active, not recruiting Longitudinal Study of Dental Implant Therapy in HIV- Positive Patients
Condition: Osseointegration Failure of Dental Implant From Complication of Systemic Disease
Intervention:
31 Active, not recruiting Vaccine Therapy in Preventing Human Papillomavirus Infection in Young HIV-Positive Male Patients Who Have Sex With Males
Conditions: Anal Cancer;   Nonneoplastic Condition;   Penile Cancer;   Precancerous Condition
Interventions: Biological: quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine;   Other: laboratory biomarker analysis
32 Completed Efficacy and Safety of GSK Biologicals HIV Vaccine in Antiretroviral Therapy (ART)-naïve HIV-1 Infected Persons
Condition: AIDS
Interventions: Biological: GSK Biologicals HIV Vaccine 732462;   Drug: Placebo
33 Recruiting EMBRACE (Evaluation of Maternal and Baby Outcome Registry After Chemoprophylactic Exposure)
Condition: Pregnancy Related
Intervention:
34 Completed Safety And Tolerability Of Multiple Dose Lersivirine For 21 Days In Healthy Subjects
Condition: Healthy Volunteers
Intervention: Drug: Lersivirine
35 Completed Estimate The Effect Of Lersivirine On The Pharmacokinetics Of Abacavir/Lamivudine In Healthy Subjects
Condition: Healthy Volunteers
Interventions: Drug: Abacavir/Lamivudine;   Drug: Lersivirine
36 Completed Family Planning Through Dairy Cooperatives
Conditions: The Study Goal is to Assess the Introduction of Sustainable Family Planning/Reproductive Health Information and Services Through;   Land O' Lakes-supported Dairy Cooperatives
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-36) Next Page   
Study has passed its completion date and status has not been verified in more than two years.